Sutro Biopharma (STRO) FCF Margin (2017 - 2025)
Sutro Biopharma (STRO) reported FCF Margin of 403.32% for Q4 2025, up 9746.0% on a YoY basis from 4.1% in Q4 2024, and up 1.47% sequentially from 409.34% in Q3 2025.
Sutro Biopharma (STRO) FCF Margin (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of FCF Margin data on file, last reported at 403.32% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 9746.0% year-over-year to 403.32%; the trailing twelve-month figure through Dec 2025 stood at 183.63% (up 13008.0% YoY), and the FY2025 full-year result was 174.59%, up 13913.0% from the prior year.
- FCF Margin rose to 403.32% in Q4 2025, from 409.34% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 269.74% in Q3 2022 to a low of 751.06% in Q3 2024.
- A 5-year average of 272.39% and a median of 305.42% in 2021 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 56556 bps in 2022 and slumped 56621 bps in 2024, its largest moves.
- Tracing STRO's FCF Margin over 5 years: stood at 326.06% in 2021, then increased by 21 bps to 259.14% in 2022, then jumped by 105 bps to 12.47% in 2023, then tumbled by 4115 bps to 500.78% in 2024, then climbed by 19 bps to 403.32% in 2025.
- Business Quant data shows STRO's FCF Margin at 403.32% in Q4 2025, 409.34% in Q3 2025, and 70.15% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -403.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -403.32% |
| Sep 30, 2025 | -409.34% |
| Jun 30, 2025 | -70.15% |
| Mar 31, 2025 | -390.31% |
| Dec 31, 2024 | -500.78% |
| Sep 30, 2024 | -751.06% |
| Jun 30, 2024 | 33.84% |
| Mar 31, 2024 | -501.13% |
| Dec 31, 2023 | 12.47% |
| Sep 30, 2023 | -184.84% |
| Jun 30, 2023 | -315.01% |
| Mar 31, 2023 | -488.66% |
| Dec 31, 2022 | -259.14% |
| Sep 30, 2022 | 269.74% |
| Jun 30, 2022 | -21.56% |
| Mar 31, 2022 | -612.79% |
| Dec 31, 2021 | -326.06% |
| Sep 30, 2021 | -295.82% |
| Jun 30, 2021 | -20.79% |
| Mar 31, 2021 | -213.09% |